These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21659761)

  • 21. Vascular endothelial growth factor (VEGF) - part 2: in endocrinology and oncology.
    Kajdaniuk D; Marek B; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2011; 62(5):456-64. PubMed ID: 22069107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].
    Valiatti FB; Crispim D; Benfica C; Valiatti BB; Kramer CK; Canani LH
    Arq Bras Endocrinol Metabol; 2011 Mar; 55(2):106-13. PubMed ID: 21584427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Enhanced Leucine-Rich
    Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
    Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
    Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
    PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic potential of angiostatin in diabetic nephropathy.
    Zhang SX; Wang JJ; Lu K; Mott R; Longeras R; Ma JX
    J Am Soc Nephrol; 2006 Feb; 17(2):475-86. PubMed ID: 16394111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
    Babapoor-Farrokhran S; Jee K; Puchner B; Hassan SJ; Xin X; Rodrigues M; Kashiwabuchi F; Ma T; Hu K; Deshpande M; Daoud Y; Solomon S; Wenick A; Lutty GA; Semenza GL; Montaner S; Sodhi A
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3030-9. PubMed ID: 26039997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair.
    Colwell AS; Beanes SR; Soo C; Dang C; Ting K; Longaker MT; Atkinson JB; Lorenz HP
    Plast Reconstr Surg; 2005 Jan; 115(1):204-12. PubMed ID: 15622252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte-derived vascular endothelial growth factor mediates the stimulation of alpha3(IV) collagen production by transforming growth factor-beta1 in mouse podocytes.
    Chen S; Kasama Y; Lee JS; Jim B; Marin M; Ziyadeh FN
    Diabetes; 2004 Nov; 53(11):2939-49. PubMed ID: 15504975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.
    Wang GM; Kovalenko B; Huang Y; Moscatelli D
    Prostate; 2007 Apr; 67(5):485-99. PubMed ID: 17221843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.
    Schrijvers BF; Flyvbjerg A; De Vriese AS
    Kidney Int; 2004 Jun; 65(6):2003-17. PubMed ID: 15149314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of VEGF and angiopoietins expression in human corpus cavernosum during aging.
    Tomada N; Tomada I; Cruz F; Vendeira P; Neves D
    J Sex Med; 2010 Apr; 7(4 Pt 1):1410-8. PubMed ID: 20059658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohn's disease patients.
    Pousa ID; Maté J; Salcedo-Mora X; Abreu MT; Moreno-Otero R; Gisbert JP
    Inflamm Bowel Dis; 2008 Jan; 14(1):61-7. PubMed ID: 17879276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and hypoxic regulation of angiopoietins in human astrocytomas.
    Ding H; Roncari L; Wu X; Lau N; Shannon P; Nagy A; Guha A
    Neuro Oncol; 2001 Jan; 3(1):1-10. PubMed ID: 11305411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.
    Sung SH; Ziyadeh FN; Wang A; Pyagay PE; Kanwar YS; Chen S
    J Am Soc Nephrol; 2006 Nov; 17(11):3093-104. PubMed ID: 16988063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2.
    Geva E; Ginzinger DG; Zaloudek CJ; Moore DH; Byrne A; Jaffe RB
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4213-24. PubMed ID: 12213874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
    Williams B
    Miner Electrolyte Metab; 1998; 24(6):400-5. PubMed ID: 9930379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.